首页 > 用药指导 > 文章详情

氢溴酸普罗维韦片首次用于猫传腹治疗,AIBIRUO猫传腹441发布

发布时间:2025-01-05 11:19:30 阅读:1355 来源:问药网
分享至

分享到微信朋友圈

×

打开微信,点击底部的“发现”,

使用“扫一扫”即可将网页分享至朋友圈。

CKBio 猫传腹441

CKBio 猫传腹441 生产厂家:老挝 XP 中草药生产有限公司 功能主治:‌用于猫传染性腹膜炎(FIP)治疗 用法用量:     【用法与用量】根据体重选择药物剂量:猫每 1 公斤体重服用半片(12.5mg/kg),  每日两次。空腹用水服用(至少在饭前 1 小时或饭后 2 小时,牛奶或其他乳制品)。或遵医嘱。  (剂量调整):猫传染性腹膜炎的症状、病程和预后会因年龄及体况不同而表现不同,兽医应结合患猫的具体临床情况进行评估,当患猫出现眼部病变(葡萄膜炎)时,建议按照 12.5~15mg/kg,每日两次给药;当患猫出现神经症状时,建议按照 15~20mg/kg,每日两次给药。  (治疗周期):治疗持续时间取决于患猫的综合体况及其治疗反应,通常建议的治疗周期为 8-12 周。  口服片剂:12.5mg/kg,每日 2 次。建议治疗 8-12 周。可参照说明书调整剂量进行给药
查看详情

氢溴酸普罗维韦片首次用于猫传腹治疗,AIBIRUO猫传腹441发布,氢溴酸普罗维韦(Providesivir Hydrobromide)用于猫传染性腹膜炎治疗,适用于猫传染性腹膜炎引起的食欲不振,精神萎靡,发烧,腹水,胸水,淋巴肿大,炎性肉芽肿,神经损伤,葡萄膜炎等症状。

AIBIRUO Cat Infectious Peritonitis Treatment 441 Launched: NeoProdesi Hydrobromide Capsules Offer New Hope for FIP Cats

In a groundbreaking development in the realm of feline health, the much-anticipated AIBIRUO Cat Infectious Peritonitis Treatment 441 has recently hit the market, heralding a new era in the management of Feline Infectious Peritonitis (FIP), a devastating disease affecting our beloved feline companions. At the core of this revolutionary treatment lies NeoProdesi Hydrobromide, known by its scientific name Providesivir Hydrobromide and also referred to as FIPV inhibitor GS-441524, offering a beacon of hope for cats battling this challenging condition.

What is Feline Infectious Peritonitis (FIP)?

FIP is a complex viral disease that affects cats, leading to symptoms such as reduced appetite, lethargy, fever, abdominal fluid accumulation, chest fluid, lymph node enlargement, inflammatory nodules, nerve damage, and ocular inflammation. Until now, effective treatment options for FIP have been limited. However, with the introduction of AIBIRUO Cat Infectious Peritonitis Treatment 441, a new ray of hope shines for feline patients suffering from this debilitating condition.

Treatment Protocol:

For optimal results, the recommended dosage of NeoProdesi Hydrobromide for cats is half a tablet per kilogram of body weight, administered twice daily. It is advised to administer the medication on an empty stomach (at least one hour before or two hours after a meal) or as directed by a veterinarian. The efficacy of this treatment in addressing the diverse symptoms associated with FIP makes it a promising therapeutic option for feline patients in need.

Product Details and Availability:

Launched in September 2024, AIBIRUO Cat Infectious Peritonitis Treatment 441 is produced by the Laotian XP Herbal Production Co., Ltd. The product is available in two packaging variants: 25mg 10 capsules and 25mg 20 capsules. Interested pet owners can purchase this groundbreaking treatment through various platforms, including the official AIBIRUO Pet Health Overseas Flagship Stores on leading e-commerce platforms such as JD.com, Tmall, and Pinduoduo.

Important Note:

While AIBIRUO Cat Infectious Peritonitis Treatment 441 offers a new ray of hope for feline patients, it is imperative to note that this product is specifically formulated for cats and should not be administered to humans. Caregivers and pet owners are advised to follow the recommended dosage guidelines and seek guidance from a qualified veterinary professional when embarking on this treatment journey for their feline companions.

The introduction of AIBIRUO Cat Infectious Peritonitis Treatment 441 marks a significant milestone in feline healthcare, offering a beacon of hope for cats battling the challenging condition of FIP. With its remarkable therapeutic efficacy, this innovative treatment stands poised to make a difference in the lives of feline patients and their devoted caregivers.